SCHEMBL6691129

SCHEMBL6691129

NC(=O)c1cccc2c1c1c(O)cccc1n2Cc1cccc(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 4/20 0.46
PLA2G2A P14555 2/20 0.46
IDO1 P14902 2/20 0.43
POLB P06746 1/20 0.43
LMNA P02545 2/20 0.43
GLA P06280 1/20 0.43
MAPK8 P45983 1/20 0.43
FABP3 P05413 1/20 0.41
FEN1 P39748 1/20 0.41
FABP4 P15090 1/20 0.40
PARP1 P09874 1/20 0.40
F2 P00734 1/20 0.40
RPS6KB1 P23443 2/20 0.39
AURKA O14965 1/20 0.39
AURKB Q96GD4 1/20 0.39
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
DRD2 P14416 1/20 0.39
HTR6 P50406 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6688565 0.89 LMNA (0.43) F10PLA2G2AIDO1POLBLMNA
SCHEMBL6770537 0.88 FABP3 (0.41) F10PLA2G2AIDO1POLBLMNA
SCHEMBL6774816 0.88 LMNA (0.43) F10PLA2G2AIDO1POLBLMNA
SCHEMBL6776450 0.86 LMNA (0.39) F10PLA2G2AIDO1POLBLMNA
SCHEMBL5212989 0.86 PLA2G2A (0.58) F10PLA2G2APARP1ALDH1A1SMN1; SMN2
SCHEMBL6690183 0.85 PLA2G2A (0.62) F10PLA2G2AMAPK8ALDH1A1
SCHEMBL6688540 0.85 F10 (0.46) F10PLA2G2ALMNAMAPK8F2
SCHEMBL6693347 0.85 PLA2G2A (0.51) F10PLA2G2APOLBMAPK8FEN1
SCHEMBL6778315 0.85 F10 (0.46) F10PLA2G2AMAPK8FEN1PARP1
SCHEMBL6772770 0.85 PLA2G2A (0.41) F10PLA2G2AIDO1POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0950657-B1 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors LILLY CO ELI (US) 2004-07-14 EP disclosed
EP-0952149-B1 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors LILLY CO ELI (US) 2004-06-09 EP disclosed
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed
EP-0950657-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors ELI LILLY AND COMPANY (US) 1999-10-20 EP disclosed